Nature Cell shares jump 14% despite CEO’s indictment for stock manipulation

the first trading day after CEO Ra Jeong-chan was indicted on charges of manipulating the stock price with false and misleading information regarding its flagship stem cell therapy last week. The stock closed 14.37 percent higher at 5,650 won (US$5.02 … (본문 전체 8/7/2018 10:19 AM)